Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reyner

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Nano Letters|August 12, 2010
Band alignment tailoring of InAs1-xSbx/GaAs quantum dots: control of type I to type II transitionJ He, C J Reyner, B L Liang, et al.
Journal of Medicinal Chemistry|February 7, 2001
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functionsJ B Smaill, G W Rewcastle, J A Loo, et al.
Diabetes, Obesity & Metabolism|April 28, 2021
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trialsAnnemarie B van der Aart-van der Beek, David Cherney, Gozewijn D Laverman, et al.
Hepatology (Baltimore, Md.)|April 1, 2024
Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty DelphiElliot B Tapper, Matthew A Warner, Rajesh P Shah, et al.
Rheumatology International|November 25, 2015
Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodiesHèctor Corominas, Vera Ortiz-Santamaría, Iván Castellví, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 4, 2012
Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network RegistryFranz Schaefer, Dagmara Borzych-Duzalka, Marta Azocar, et al.
Biochemical and Biophysical Research Communications|April 25, 1996
Nonpeptidic HIV protease inhibitors: 4-hydroxy-pyran-2-one inhibitors with functional tethers to P1 phenyl ring to reach S3 pocket of the enzymeJ Vara Prasad, P J Tummino, D Ferguson, et al.
Plos One|March 14, 2017
Poor phenotype-genotype association in a large series of patients with Type III Bartter syndromeAlejandro García Castaño, Gustavo Pérez de Nanclares, Leire Madariaga, et al.
Pediatric Nephrology (Berlin, Germany)|November 2, 2019
Colostomy in children on chronic peritoneal dialysisEugene Y H Chan, Dagmara Borzych-Duzalka, Caner Alparslan, et al.
Breast Cancer Research and Treatment|August 2, 2019
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancerVandana G Abramson, Mafalda Oliveira, Andrés Cervantes, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Nano Letters|August 12, 2010
Band alignment tailoring of InAs1-xSbx/GaAs quantum dots: control of type I to type II transitionJ He, C J Reyner, B L Liang, et al.
Journal of Medicinal Chemistry|February 7, 2001
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functionsJ B Smaill, G W Rewcastle, J A Loo, et al.
Diabetes, Obesity & Metabolism|April 28, 2021
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trialsAnnemarie B van der Aart-van der Beek, David Cherney, Gozewijn D Laverman, et al.
Hepatology (Baltimore, Md.)|April 1, 2024
Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty DelphiElliot B Tapper, Matthew A Warner, Rajesh P Shah, et al.
Rheumatology International|November 25, 2015
Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodiesHèctor Corominas, Vera Ortiz-Santamaría, Iván Castellví, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 4, 2012
Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network RegistryFranz Schaefer, Dagmara Borzych-Duzalka, Marta Azocar, et al.
Biochemical and Biophysical Research Communications|April 25, 1996
Nonpeptidic HIV protease inhibitors: 4-hydroxy-pyran-2-one inhibitors with functional tethers to P1 phenyl ring to reach S3 pocket of the enzymeJ Vara Prasad, P J Tummino, D Ferguson, et al.
Plos One|March 14, 2017
Poor phenotype-genotype association in a large series of patients with Type III Bartter syndromeAlejandro García Castaño, Gustavo Pérez de Nanclares, Leire Madariaga, et al.
Pediatric Nephrology (Berlin, Germany)|November 2, 2019
Colostomy in children on chronic peritoneal dialysisEugene Y H Chan, Dagmara Borzych-Duzalka, Caner Alparslan, et al.
Breast Cancer Research and Treatment|August 2, 2019
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancerVandana G Abramson, Mafalda Oliveira, Andrés Cervantes, et al.
Pageof 15